| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 5 | CA 1 | 99.80 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 17 | CA 2 | 99.66 |
| Molecular Biology Techniques and Applications | Lifetime | 21 | CA 1 | 99.57 |
| Peptidase Inhibition and Analysis | Lifetime | 47 | CA 2 | 99.72 |
| Advanced Biosensing Techniques and Applications | Lifetime | 18 | CA 1 | 99.32 |
| Prostate Cancer Treatment and Research | Lifetime | 61 | CA 6 | 99.74 |
| Advanced Proteomics Techniques and Applications | Lifetime | 28 | CA 1 | 99.47 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 111 | CA 5 | 99.04 |
| Cancer Genomics and Diagnostics | Lifetime | 240 | CA 10 | 99.50 |
| S100 Proteins and Annexins | Lifetime | 62 | CA 1 | 98.95 |
| Estrogen and related hormone effects | Lifetime | 194 | CA 6 | 99.12 |
| Mass Spectrometry Techniques and Applications | Lifetime | 260 | CA 19 | 98.85 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 175 | CA 10 | 99.39 |
| Cancer, Lipids, and Metabolism | Lifetime | 230 | CA 14 | 99.03 |
| Urologic and reproductive health conditions | Lifetime | 127 | CA 6 | 99.14 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 59 | CA 3 | 98.32 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 673 | CA 19 | 98.89 |
| Ferroptosis and cancer prognosis | Lifetime | 188 | CA 5 | 97.54 |
| Analytical Chemistry and Sensors | Lifetime | 517 | CA 8 | 98.56 |
| Cell Adhesion Molecules Research | Lifetime | 390 | CA 14 | 98.71 |
| Biotin and Related Studies | Lifetime | 64 | CA 5 | 97.64 |
| Cancer-related Molecular Pathways | Lifetime | 410 | CA 12 | 98.55 |
| Advanced biosensing and bioanalysis techniques | Lifetime | 884 | CA 19 | 98.36 |
| GDF15 and Related Biomarkers | Lifetime | 43 | CA 2 | 96.92 |
| Protease and Inhibitor Mechanisms | Lifetime | 320 | CA 15 | 97.83 |
| Ovarian cancer diagnosis and treatment | Lifetime | 492 | CA 25 | 97.98 |
| Tea Polyphenols and Effects | Lifetime | 148 | CA 4 | 97.25 |
| Lung Cancer Treatments and Mutations | Lifetime | 987 | CA 28 | 98.10 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 319 | CA 22 | 97.42 |
| Genetic factors in colorectal cancer | Lifetime | 698 | CA 15 | 97.70 |
| Hormonal and reproductive studies | Lifetime | 547 | CA 23 | 97.45 |
| Lanthanide and Transition Metal Complexes | Lifetime | 594 | CA 10 | 97.11 |
| Phytochemical compounds biological activities | Lifetime | 160 | CA 5 | 96.69 |
| Biomarkers in Disease Mechanisms | Lifetime | 113 | CA 5 | 95.45 |
| Cancer Research and Treatments | Lifetime | 832 | CA 19 | 96.25 |
| Health and Medical Research Impacts | Lifetime | 245 | CA 21 | 94.72 |
| Galectins and Cancer Biology | Lifetime | 779 | CA 31 | 93.89 |
| vaccines and immunoinformatics approaches | Lifetime | 605 | CA 8 | 94.06 |
| Xenotransplantation and immune response | Lifetime | 394 | CA 15 | 91.20 |
| Kruppel-like factors research | Lifetime | 881 | CA 32 | 87.50 |
| Male Breast Health Studies | Lifetime | 187 | CA 10 | 83.29 |
| Academic Publishing and Open Access | Lifetime | 162 | CA 13 | 83.43 |
| scientometrics and bibliometrics research | Lifetime | 731 | CA 40 | 85.18 |
| Clinical Laboratory Practices and Quality Control | Lifetime | 941 | CA 44 | 78.66 |
| Clusterin in disease pathology | Lifetime | 406 | CA 29 | 66.25 |
| Genetic factors in colorectal cancer | 2021-2025 | 820 | CA 27 | 87.74 |
